SWEISS, Nadera J. et al. Efficacy Results of a 52-week Trial of Adalimumab in the Treatment of Refractory Sarcoidosis. Sarcoidosis, Vasculitis and Diffuse Lung Diseases, Fidenza, Italy, v. 31, n. 1, p. 46–54, 2014. Disponível em: https://mail.mattioli1885journals.com/index.php/sarcoidosis/article/view/2943. Acesso em: 21 aug. 2025.